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Atopic Dermatitis and Disease Severity Are the
Main Risk Factors for Food Sensitization in
Exclusively Breastfed Infants
Carsten Flohr1,2,4, Michael Perkin2,4, Kirsty Logan2, Tom Marrs2, Suzana Radulovic2, Linda E. Campbell3,
Stephanie F. MacCallum3, W.H. Irwin McLean3 and Gideon Lack2
Filaggrin (FLG) loss-of-function skin barrier gene mutations are associated with atopic dermatitis (AD) and
transepidermal water loss (TEWL). We investigated whether FLG mutation inheritance, skin barrier impairment,
and AD also predispose to allergic sensitization to foods. Six hundred and nineteen exclusively breastfed infants
were recruited at 3 months of age and examined for AD and disease severity (SCORing Atopic Dermatitis
(SCORAD)), and screened for the common FLG mutations. TEWL was measured on unaffected forearm skin. In
addition, skin prick testing was performed to six study foods (cow’s milk, egg, cod, wheat, sesame, and peanut).
Children with AD were significantly more likely to be sensitized (adjusted odds ratio (OR)¼ 6.18, 95% confidence
interval (CI): 2.94–12.98, Po0.001), but this effect was independent of FLG mutation carriage, TEWL, and AD
phenotype (flexural vs. non-flexural). There was also a strong association between food sensitization and AD
severity (adjusted ORSCORADo20¼ 3.91, 95% CI: 1.70–9.00, P¼ 0.001 vs. adjusted ORSCORADX20¼ 25.60, 95% CI: 9.03–
72.57, Po0.001). Equally, there was a positive association between AD and sensitization with individual foods
(adjusted ORegg¼ 9.48, 95% CI: 3.77–23.83, Po0.001; adjusted ORcow’s milk¼ 9.11, 95% CI: 2.27–36.59, P¼ 0.002;
adjusted ORpeanut¼ 4.09, 95% CI: 1.00–16.76, P¼ 0.05). AD is the main skin-related risk factor for food sensitization
in young infants. In exclusively breastfed children, this suggests that allergic sensitization to foods can be
mediated by cutaneous antigen-presenting cells.
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INTRODUCTION
The recent discovery of the common loss-of-function variants
in the filaggrin (FLG) gene, encoding the epidermal barrier
protein FLG, and the strong association with atopic disease,
has led to a heightened interest in the role of skin barrier
dysfunction in the development of atopic dermatitis (AD),
allergic sensitization, and also respiratory allergies (Irvine
et al., 2006; Palmer et al., 2006; Smith et al., 2006;
Sandilands et al., 2007; Boralevi et al., 2008; Sandilands
et al., 2009). The current hypothesis is that in individuals
without a skin barrier defect, there is full integrity of the
epidermis marked by minimal transepidermal water loss
(TEWL) and adequate protection against environmental
insults, such as microbes and environmental allergens.
However, where people carry a skin barrier gene mutation,
such as a loss-of-function mutation in the FLG gene, TEWL is
increased. Probably in interaction with environmental factors,
such as frequent use of protease-containing detergents and
soaps, the integrity of the skin barrier is gradually broken
down, and this may lead to the typical immunological
changes seen in eczematous skin (Cork et al., 2006). Animal
work suggests that environmental allergens, such as house
dusts mites but also food protein, can make contact with the
immune system via antigen-presenting cells in the superficial
epidermis, leading to sensitization, which could potentially
make existing AD worse and may also be an important
precursor of food and respiratory allergies (Lack et al., 2003;
Fallon et al., 2009). This would explain why FLG mutations
are only associated with asthma in the presence of AD and/or
allergic sensitization (van den Oord and Sheikh, 2009).
However, none of the above has been demonstrated in a
prospective study setting, and therefore the exact sequence of
events remains uncertain.
At present, we only have evidence from studies among
older children and adults, which suggests that those who
carry a FLG skin barrier gene mutation have a higher
risk of developing AD, early-onset disease, and more severe
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disease compared with wild-type children (Barker et al., 2007;
Brown et al., 2008; Nemoto-Hasebe et al., 2009; Ezzedine
et al., 2012).
We have recently shown that FLG mutation carriage is
associated with early-onset AD. Carrying at least one FLG
mutation was also significantly associated with raised TEWL,
even in the absence of AD, suggesting that skin barrier
impairment may be an important precursor of eczematous
skin inflammation (Flohr et al., 2010). Furthermore, we have
demonstrated a positive association between FLG mutation
carriage, parental report of AD symptoms, and challenge-
proven peanut allergy in school children (Brown et al., 2011).
The association between AD and peanut allergy remained
significant even after adjustment for FLG status, which suggests
that eczematous skin inflammation can act as a mediator of
food sensitization. However, early food sensitization, AD
severity, and TEWL were not assessed in this cohort.
We therefore tested the hypothesis that inheritance of FLG
mutations, skin barrier impairment (raised TEWL), and AD
increase the risk of food sensitization in a cohort of 3-month–
old infants who were all exclusively breastfed.
RESULTS
The association between AD, FLG, and TEWL
A total of 24.9% (154/619) of children had clinical AD, with a
median SCORing Atopic Dermatitis (SCORAD index) of 7.6
(range 3.5–71.5). One hundred and thirty-two of 154 children
(85.7%) had mild AD (SCORAD o20) and 22/154 (14.3%)
had moderate-to-severe disease (SCORAD X20). Median
TEWL (g (m2h)1) in infants without AD was 12.18 (inter-
quartile range (IQR), 10.24–14.96) and significantly lower
compared with affected children, 15.41 (IQR, 12.30–21.83,
Po0.001). Higher TEWL was associated with more severe
disease, r¼ 0.55 (Po0.001), median TEWL ‘SCORAD o20’
14.7 (IQR, 12.2–18.8) versus ‘SCORAD X20’ 26.4, (IQR,
15.4–39.7, Po0.001). In our children, 12.1% (75/619) carried
at least one FLG mutation, of which 70 (93.3%) were
heterozygotes and 5 (6.7%) were either homozygous or
compound heterozygotes. The prevalence of FLG mutations
increased to 24.0% (37/154) among children with AD. FLG
mutation carriers were more likely to have AD by 3 months of
age (odds ratio (OR)¼ 3.55, 95% confidence interval (CI):
2.16–5.84, Po0.001). In addition, FLG mutations were
Table 1. The association between FLG, TEWL, AD, and food sensitization risk (SPT X1mm)
N (%)
Any food
sensitization, N (%) Crude OR (95% CI) P-value
OR adjusted for sex
and FLG (95% CI) P-value
FLG mutation
No 544 (87.9) 29 (5.3) 1 1
Yes 75 (12.1) 5 (6.7) 1.27 (0.48–3.38) 0.64 1.211 (0.45–3.24) 0.70
TEWL
o15 (g (m2 h) 1) 425 (68.7) 15 (3.5) 1 1
X15 (g (m2 h) 1) 194 (31.3) 19 (9.8) 2.96 (1.47–5.96) 0.002 3.261 (1.61–6.62) 0.001
AD
No 465 (75.1) 13 (2.8) 1
Yes 154 (24.9) 21 (13.6) 5.49 (2.68–11.26) o0.001 6.18 (2.94–12.98) o0.001
AD severity
No AD 465 (75.1) 13 (2.8) 1 Ptrendo0.001 1 Ptrendo0.001
SCORAD o20 132 (21.3) 12 (9.1) 3.47 (1.55–7.82) 0.003 3.91 1.70–9.00 0.001
SCORAD X20 22 (3.6) 9 (40.9) 24.07 (8.74–66.29) o0.001 25.60 (9.03–72.57) o0.001
AD phenotype
No AD 465 (75.1) 13 (2.8) 1 Ptrendo0.001 1 Ptrend 0.23
Flexural AD only 44 (7.1) 2 (4.5) 1.65 (0.36–7.60) 0.51 0.982 (0.20–4.91) 0.98
Non-flexural AD only 36 (5.8) 5 (13.9) 5.62 (1.88–16.78) 0.002 3.072 (0.92–10.28) 0.26
Both flexural and
non-flexural AD
74 (12.0) 14 (19.2) 8.27 (3.71–18.44) o0.001 2.552 (0.74–8.83) 0.77
Abbreviations: AD, atopic dermatitis; CI, confidence interval; FLG, filaggrin; OR, odds ratio; SCORAD, SCORing Atopic Dermatitis; SPT, skin prick test; TEWL,
transepidermal water loss.
1Only adjusted for sex.
2Adjusted for FLG, sex, and AD severity (SCORAD).
Bold values indicate Po0.05 conventional statistical significance.
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significantly associated with higher median TEWL: all children
FLG ‘yes’ 15.77 (IQR, 12.31–25.52) versus FLG ‘no’ 12.43
(IQR, 10.46–15.38, Po0.001). This effect was true even in the
absence of clinical AD: FLG ‘yes’ 14.15 (IQR, 12.16–16.81)
versus FLG ‘no’ 11.94 (IQR, 10.19–14.77, Po0.001).
The association between AD, FLG, TEWL, and food sensitization
With regard to food sensitization, 5.5% of children (34/619)
were sensitized to one of the six study foods (skin prick test
(SPT) X1 mm), or 4.0% (25/619) using 3 mm as the SPT
diameter cutoff. Egg white sensitization was the most common
(n¼ 24), followed by cow’s milk (n¼ 10), peanut (n¼8), and
wheat (n¼2). None of the children were sensitized to cod fish
or sesame. FLG mutations were not significantly associated
with food sensitization (adjusted OR all children¼1.21, 95%
CI: 0.45–3.24, P¼ 0.70 (Table 1); adjusted OR children with
AD¼1.48, 95% CI: 0.46–4.75 vs. adjusted OR children
without AD¼ 1.18, 95% CI: 0.15–9.40). There was a sig-
nificant association between TEWL and food sensitization
(TEWLo vs. 415 g(m2h)1; adjusted OR¼3.26, 95% CI:
1.61–6.62, P¼0.001; Table 1). This remained significant
when adjusted for both FLG mutation status and AD presence,
but became nonsignificant following adjustment for AD
severity (Table 2). AD presence and severity were themselves
strongly associated with food sensitization (Table 1; SPT
X1 mm). The results became even more significant when an
SPT diameter cutoff of 3 mm was used (adjusted OR¼8.53,
95% CI: 3.51–20.65, Po0.001; adjusted ORSCORADo20¼ 4.44,
1.60–12.34, 95% CI: P¼0.004; and adjusted ORSCORADX20¼
45.77, 95% CI: 14.47–144.81, Po0.001). Similar associations
were found for individual sensitization to egg, cow’s milk, and
peanut (Table 3; SPT X1 mm), and the 3-mm cutoff risk
estimates were as follows: adjusted ORegg¼9.29, 95% CI:
3.43–25.18, Po0.001; adjusted ORcow’s milk¼ 11.14, 95% CI:
2.17–57.18, P¼0.004; and adjusted ORpeanut¼7.87, 95%
CI: 0.70–88.20, P¼ 0.09. Although AD phenotypye (no AD
vs. flexural vs. non-flexural vs. both flexural and non-flexural)
showed a highly significant stepwise increase in food sensiti-
zation risk, this was mediated by disease severity (SCORAD)
rather than being specific to the disease site (Table 1).
DISCUSSION
We have shown that early-onset AD and disease severity as
well as skin barrier impairment (TEWL) are associated with the
risk of food sensitization at 3 months of age, whereas FLG
mutation carriage was not an independent risk factor. AD
phenotype was acting as a proxy for AD severity.
To the best of our knowledge, the association between FLG
mutations, AD, disease severity, disease phenotype, and food
sensitization during the first 3 months of life has not been
reported previously. A strength of our study is that we
physically examined all children for AD, rather than relying
on parental report of a doctor diagnosis. In addition, we
measured AD severity and TEWL as a measure of phenotypic
skin barrier impairment. Our data suggest that this was a
sensitive outcome, given that we detected significant TEWL
differences in association with FLG mutations even in the
absence of clinical AD. We were also able to examine the
effect of AD and disease severity on individual food allergens.
However, it is important to keep in mind that food
sensitization does not always equate to clinical allergy, and
longitudinal follow-up of our cohort is underway, which will
include double-blind, placebo–controlled food challenges. In
addition, we only performed skin prick testing, rather than
specific immunoglobulin E measurements, but the former is
considered to be a more specific predictor of clinical food
allergy in later life (Osborne et al., 2011).
As all our study children were exclusively breastfed and
food protein levels are relatively low in breastmilk (COT
Statement UK Department of Health, 2008), it is possible that
food sensitization was mediated via antigen-presenting cells in
the skin rather than the gut. This concept is supported by our
observation that the topical use of peanut oil containing
preparations increases the risk of peanut allergy, in parti-
cular in children with a history of AD (Lack et al., 2003). In
addition, our case–control study on the association between
AD and peanut allergy in older children suggested a seven
times increased risk of challenge-proven peanut allergy
between 1 and 18 years of age in association with a history
of AD between 6 and 42 months (adjusted OR¼7.4, 95% CI:
4.1–13.7), even when FLG mutation carriage status was taken
Table 2. Joint modeling of the effect of the skin variables on food sensitization exploring evidence of collinearity
Food sensitization (SPT X1mm)
FLG, OR (95% CI) TEWL, OR (95% CI) AD, OR (95% CI) SCORAD, OR (95% CI)
Any mutation X15 (g (m2h) 1) Yes o20 X20
FLG 1.21 (0.45–3.24) — — — —
FLG, TEWL 0.88 (0.32–2.41) 3.32 (1.61–6.83)z — — —
FLG, TEWL, AD 0.59 (0.21–1.68) 2.23 (1.04–4.76)* 5.03 (2.33–10.8)y — —
FLG, TEWL, SCORAD 0.63 (0.21–1.86) 1.74 (0.77–3.90) — 3.49 (1.49–8.18)w 19.1 (6.21–58.8)y
Abbreviations: AD, atopic dermatitis; CI, confidence interval; FLG, filaggrin; OR, odds ratio; SCORAD, SCORing Atopic Dermatitis; SPT, skin prick test; TEWL,
transepidermal water loss.
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into account (Brown et al., 2011). Interestingly, in the same
study, we also found a significant independent risk increase in
peanut allergy in association with carriage of an FLG loss-of-
function mutation (OR¼3.8, 95% CI: 1.7–8.3), but no
measure of skin barrier impairment was included and
adjusted for in the analysis.
Although there is mounting evidence for percutaneous
sensitization in individuals with inflamed skin, and experi-
mental evidence for increased percutaneous sensitization in
FLG-deficient mice, the role of skin barrier gene mutations and
skin barrier impairment in the development of AD and food
allergy requires further research. It is likely that there are other
hitherto undiscovered skin barrier genes involved. In addition,
it is important to study the interplay between genetic and
environmental factors, such as water hardness, hygiene
practices, and the microbiome of the skin.
It is also conceivable that there are other routes to food
allergy development than the skin barrier, such as transpla-
centally or via the gut mucosa, as we know from clinical
experience that children can become sensitized to foods
without prior development of AD. Building on the hygiene
hypothesis and the emerging understanding of the role of
bacteria within the host microbiota in the development and
maintenance of epithelial cell integrity and tolerance, it has
recently been proposed that a lowered bacterial species
diversity not only on the skin but also in the gut may lead to
inadequate stimulation of immunoregulatory networks,
predisposing to food allergy and AD (Rook, 2009;
Hooper et al., 2012). The timing of solid food introduction
may be very important in this context, and we are currently
testing the hypothesis that the early introduction of allergenic
foods at 3 months of age alongside breastfeeding versus
exclusive breastfeeding for 6 months reduces the risk of food
allergy and AD in the same cohort of children (http://
www.eatstudy.co.uk).
We are only beginning to understand how genetic and
environmental factors interact at the level of the gut mucosa
and the skin, and, systemically, how this leads to the
development of AD and food allergy. The results reported
here form a small piece of this jigsaw puzzle and much further
Table 3. The association between FLG, TEWL, AD, and food sensitization to individual allergens (SPT X1mm)
N (%)
Any food
sensitization, N (%) Crude OR (95% CI) P-value
OR adjusted for sex and
FLG (95% CI) P-value
Egg sensitization
AD
No 465 (75.1) 7 (1.5) 1 1
Yes 154 (24.9) 17 (11.0) 8.12 (3.30–19.98) o0.001 9.48 (3.77–23.83) o0.001
AD severity
No AD 465 (75.1) 7 (1.5) 1 Ptrendo0.001 1 Ptrendo0.001
SCORAD o20 132 (21.3) 9 (6.8) 4.78 (1.75–13.11) 0.002 5.59 (2.00–15.61) 0.001
SCORAD X20 22 (3.6) 8 (36.4) 37.39 (11.89–117.53) o0.001 41.38 (12.75–134.35) o0.001
Cow’s milk sensitization
AD
No 465 (75.1) 3 (0.6) 1 1
Yes 154 (24.9) 7 (4.5) 7.33 (1.87–28.72) 0.004 9.11 (2.27–36.59) 0.002
AD severity
No AD 465 (75.1) 3 (0.6) 1 Ptrend¼ 0.001 1 Ptrendo0.001
SCORAD o20 132 (21.3) 4 (3.0) 4.81 (1.06–21.78) 0.04 6.04 (1.30–28.08) 0.02
SCORAD X20 22 (3.6) 3 (13.6) 24.32 (4.60–128.50) o0.001 26.55 (4.84–145.61) o0.001
Peanut sensitization
AD
No 465 (75.1) 4 (0.9) 1 1
Yes 154 (24.9) 4 (2.6) 3.07 (0.76–12.44) 0.12 4.09 (1.00–16.76) 0.05
AD severity
No AD 465 (75.1) 4 (0.9) 1 Ptrend¼ 0.001 Ptrend¼0.002
SCORAD o20 132 (21.3) 2 (1.5) 1.77 (0.32–9.79) 0.05 2.39 (0.43–13.36) 0.32
SCORAD X20 22 (3.6) 2 (9.1) 11.53 (1.99–66.68) 0.006 13.65 (2.28–81.62) 0.004
Abbreviations: AD, atopic dermatitis; CI, confidence interval; FLG, filaggrin; OR, odds ratio; SCORAD, SCORing Atopic Dermatitis; SPT, skin prick test; TEWL,
transepidermal water loss.
Bold values indicate Po0.05 conventional statistical significance.
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work is required. It is hoped that this will not only lead to a
better understanding of the pathoetiology of AD and food
allergy but also ultimately to the development of novel
therapeutic interventions and methods of disease prevention.
MATERIALS AND METHODS
Our study was approved by the Research Ethics Committee of Guy’s
& St Thomas’ Hospitals Foundation Trust and was conducted
according to the Declaration of Helsinki Principles. Six hundred
and nineteen 3-month–old exclusively breastfed infants were
recruited from the general population in England and Wales through
direct advertising between October 2009 and April 2012 for an
interventional trial. All children had been born at term (X37 weeks
gestation). Following written informed parental consent and before
randomization to the study interventions, children were examined for
AD, using the UK diagnostic criteria–based photographic protocol of
the International Study of Asthma and Allergies in Childhood (ISAAC)
Phase Two (Weiland et al., 2004). Disease severity was determined
by the SCORAD index and disease phenotype was recorded
(‘flexural’ (either around the eyes, neck, antecubital, and popiteal
fossae or ankles) or ‘non-flexural’) (Kunz et al., 1997). TEWL was
measured with the Biox Aquaflux AF200 (Biox, London, UK) closed
condenser chamber device on the unaffected skin of the volar aspect
of the forearm (Farahmand et al., 2009). Participants’ parents were
advised not to use any skin care products on the infant’s arms for the
preceding 24 hours. Measurements were performed in our
environmentally controlled Clinical Research Facility (ambient
temperature 20±2 1C, relative room humidity 32–50%), after at least
20 minutes of acclimatization. Measurements were not taken if the
child was visibly distressed or crying. In all children, we calculated
the mean of three separate TEWL measurements. We measured
allergic sensitization through skin prick testing, as this has been
shown to be more specific as a predictor of clinical food allergy in
later life than serum-specific immunoglobulin E (Osborne et al.,
2011). Skin prick testing was performed in duplicate to the six most
common allergenic foods in the United Kingdom using a combination
of whole foods (fresh cow’s milk, raw hen’s egg white, and sesame
(tahini) paste) and commercial solutions (peanut, wheat, and cod
fish), as well as histamine (10 mg ml 1) and normal saline control
solutions (all commercial SPT solutions; Stallergenes, Didcot, UK).
A drop of each allergen and both control solutions were placed onto
the volar aspect of uninvolved skin of the forearm and pierced
vertically using 1 mm ALK lancets (Hrsholm, Denmark). Reactions
were recorded after 15 minutes. Two thresholds for determining
positive SPTs were used in this study, as the predictive value of
SPTs at such an early age is unknown: any reaction X1 mm (primary
outcome) and any reaction X3 mm (secondary outcome). Food
sensitization was defined as having at least one positive SPT to any
of the allergens tested. Venous blood samples were screened for
the six most common FLG mutations (R501X, 2282del4, R2447X,
S3247X, 3673delC, and 3702delG), using the TaqMan allelic
discrimination assay (Applied Biosystems, ABI 7900 HT, Foster City,
CA). We used the Mann–Whitney U-test and Spearman’s correlation
coefficients to examine median SCORAD and TEWL measurements
(both were non-normally distributed) in children with and without AD
and FLG mutations, using IBM SPSS version 20 (Sun Microsystems,
Santa Clara, CA). Where appropriate, we calculated OR estimates
and corresponding 95% CIs, including the association between FLG
mutation carriage, TEWL, AD, and food sensitization. All OR
estimates were adjusted for sex as a priori confounder. We also
explored the effect of the degree of TEWL elevation (o15 vs.
415 g (m2 h) 1—cutoff based on the TEWL IQR in unaffected
children), AD severity (mild disease SCORAD o20 vs. moderate-to-
severe disease SCORAD X20) and AD phenotype (no AD vs. pure
flexural vs. pure non-flexural vs. both flexural and non-flexural AD)
on food sensitization risk. As some of the AD variables are strongly
correlated (e.g., AD phenotype and severity) and some others
potentially on a causal pathway (TEWL is likely to be on the causal
pathway between FLG mutation carriage and AD development), we
specifically looked for evidence of collinearity influencing the
statistical analyses (Schisterman et al., 2009).
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